Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Martínez Monge, Rafael ^a   Pagola Divassón, María ^a   Cambeiro, Mauricio ^a   Gaztañaga, Miren ^a   Moreno, Marta ^a   Arbea, Leire ^a   Montesdeoca, Néstor ^a   Alcalde, Juan ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Brachytherapy; Cisplatin; External beam radiation; High dose rate; Paclitaxel; Perioperative; Primary head and neck cancer; Recurrent head and neck cancer; Reirradiation; Squamous cell carcinoma

Indexed keywords

BRACHYTHERAPY; CIS-PLATIN; EXTERNAL BEAM RADIATION; HEAD-AND-NECK CANCER; HIGH DOSE RATE; PACLITAXEL; PERIOPERATIVE; REIRRADIATION; SQUAMOUS CELL CARCINOMA;

CHEMOTHERAPY; DISEASES; IRRADIATION; ONCOLOGY; PLATINUM COMPOUNDS; RADIATION; TUMORS;

RADIOTHERAPY;

CISPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; BLEEDING; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PEROPERATIVE HIGH DOSE RATE BRACHYTHERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; TISSUE NECROSIS; TREATMENT DURATION; TREATMENT OUTCOME; WOUND COMPLICATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT FAILURE;

EID: 80955179538     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.026     Document Type: Article

References (27)

1. National Comprehensive Cancer Network Practice guidelines in oncology v 2 2010 National Comprehensive Cancer Network Fort Washington, PA
2. M. Lapeyre, D. Peiffert, and S. Hoffstetter Post-operative brachytherapy: A prognostic factor for local control in epidermoid carcinomas of the mouth floor Eur J Surg Oncol 23 1997 243 246 (Pubitemid 27343156)
3. J.J. Beitler, R.V. Smith, and C.E. Silver Close or positive margins after surgical resection for the head and neck cancer patient: The addition of brachytherapy improves local control Int J Radiat Oncol Biol Phys 40 1998 313 317 (Pubitemid 28114374)
4. M. Lapeyre, S. Hoffstetter, and D. Peiffert Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins Int J Radiat Oncol Biol Phys 48 2000 37 42 (Pubitemid 30488210)
5. M. Lapeyre, M.A. Bollet, and S. Racadot Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins Head Neck 26 2004 216 223 (Pubitemid 38292731)
6. G.G. Grabenbauer, C. Rodel, and T. Brunner Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997 Strahlenther Onkol 177 2001 338 344 (Pubitemid 32673153)
7. W.J. Melzner, M. Lotter, and R. Sauer Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: Predictive factors for local control and late toxicity? Radiother Oncol 82 2007 167 173 (Pubitemid 46275134)
8. A.C. Pellizzon, J.V. Salvajoli, and L.P. Kowalski Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy Radiat Oncol 1 2006 27
9. C. Nutting, N. Horlock, and R. A'Hern Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer Radiother Oncol 80 2006 39 42 (Pubitemid 44205312)
10. A. Narayana, G.N. Cohen, and M. Zaider High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers - Preliminary results Brachytherapy 6 2007 157 163 (Pubitemid 46551961)
11. M.E. Kupferman, W.H. Morrison, and A.A. Santillan The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers Cancer 109 2007 2052 2057 (Pubitemid 46744200)
12. F. Schiefke, G. Hildebrandt, and S. Pohlmann Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas J Craniomaxillofac Surg 36 2008 285 292
13. R. Martinez-Monge, J. Alcalde, and C. Concejo Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study Brachytherapy 5 2006 32 40
14. R. Martinez-Monge, A. Gomez-Iturriaga, and M. Cambeiro Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer Brachytherapy 8 2009 26 33
15. L. Grimard, B. Esche, and A. Lamothe Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies Head Neck 28 2006 888 895 (Pubitemid 44497864)
16. L. Grimard, B. Esche, and A. Lamothe Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy Brachytherapy 8 2009 284 289
17. K.K. Ang, A. Trotti, and B.W. Brown Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 51 2001 571 578
18. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952 (Pubitemid 38580197)
19. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
20. J.S. Cooper, T.F. Pajak, and A. Forastiere Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: Targets for postoperative radiochemotherapy? Head Neck 20 1998 588 594 (Pubitemid 28405799)
21. International Commission on Radiation Units and Measurements Dose and volume specification for reporting interstitial therapy. ICRU report 58 1997 International Commission on Radiation Units and Measurements Bethesda
22. International Commission on Radiation Units and Measurements Prescribing, recording and reporting photon beam therapy. ICRU report 62 1999 International Commission on Radiation Units and Measurements Bethesda
23. Late effects consensus conference: RTOG/EORTC Radiother Oncol 35 1995 5 7
24. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
25. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
26. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 187 220
27. F. Janot, D. de Raucourt, and E. Benhamou Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma J Clin Oncol 26 2008 5518 5523